FZD4
Frizzled-4
Also known as: CD344, EVR1, FZD4_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9ULV1
- Gene
- FZD4
- Ensembl
- ENSG00000174804
- Chromosome
- 11
- Canonical length
- 537 aa
- Protein class
- CD markers, Disease related genes, G-protein coupled receptors, Human disease related genes, Potential drug targets, Predicted membrane proteins
- Subcellular location
- Nucleoplasm,Plasma membrane,Primary cilium
OverviewNCBI Gene
This gene is a member of the frizzled gene family. Members of this family encode seven-transmembrane domain proteins that are receptors for the Wingless type MMTV integration site family of signaling proteins. Most frizzled receptors are coupled to the beta-catenin canonical signaling pathway. This protein may play a role as a positive regulator of the Wingless type MMTV integration site signaling pathway. A transcript variant retaining intronic sequence and encoding a shorter isoform has been described, however, its expression is not supported by other experimental evidence. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
537 residues, UniProt reviewed canonical sequence.
>Q9ULV1|FZD4
1 MAWRGAGPSV PGAPGGVGLS LGLLLQLLLL LGPARGFGDE EERRCDPIRI SMCQNLGYNV
61 TKMPNLVGHE LQTDAELQLT TFTPLIQYGC SSQLQFFLCS VYVPMCTEKI NIPIGPCGGM
121 CLSVKRRCEP VLKEFGFAWP ESLNCSKFPP QNDHNHMCME GPGDEEVPLP HKTPIQPGEE
181 CHSVGTNSDQ YIWVKRSLNC VLKCGYDAGL YSRSAKEFTD IWMAVWASLC FISTAFTVLT
241 FLIDSSRFSY PERPIIFLSM CYNIYSIAYI VRLTVGRERI SCDFEEAAEP VLIQEGLKNT
301 GCAIIFLLMY FFGMASSIWW VILTLTWFLA AGLKWGHEAI EMHSSYFHIA AWAIPAVKTI
361 VILIMRLVDA DELTGLCYVG NQNLDALTGF VVAPLFTYLV IGTLFIAAGL VALFKIRSNL
421 QKDGTKTDKL ERLMVKIGVF SVLYTVPATC VIACYFYEIS NWALFRYSAD DSNMAVEMLK
481 IFMSLLVGIT SGMWIWSAKT LHTWQKCSNR LVNSGKVKRE KRGNGWVKPG KGSETVVLocalizationUniProt · AlphaFold · HPA
Whether an antibody against FZD4 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 7
- Mean surface accessibility (rSASA)
- 0.32
- Highest tissue expression
- 113 nTPM
Expression across tissuesHPA
Tissue
- adipose tissue: 113 nTPM
- breast: 55 nTPM
- tongue: 38 nTPM
- lung: 31 nTPM
- skeletal muscle: 29 nTPM
- seminal vesicle: 29 nTPM
Single-cell type
- adipocytes: 190 nCPM
- vascular endothelial cells: 92 nCPM
- distal convoluted tubule cells: 78 nCPM
- renal connecting tubule cells: 66 nCPM
- thymic myoid cells: 59 nCPM
- pituitary stem cells: 58 nCPM
Immune cell
- NK-cell: 0.1 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
Brain region
- thalamus: 17 nTPM
- choroid plexus: 15 nTPM
- cerebral cortex: 14 nTPM
- pons: 13 nTPM
- amygdala: 12 nTPM
- medulla oblongata: 12 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about FZD4.
Disease | AllUniProt
Conditions FZD4 is implicated in, by any mechanism.
- Vitreoretinopathy, exudative 1 (EVR1) MIM:133780
Disease | GeneticClinVar
82 pathogenic / likely-pathogenic of 546 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Exudative vitreoretinopathy 1
- Retinal dystrophy
- Familial exudative vitreoretinopathy
- Coats disease
- Exudative vitreoretinopathy, digenic
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.31
- gnomAD pLI
- 0.97
- gnomAD missense Z
- 0.73
- DepMap mean gene effect
- 0.12
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- angiogenesis
- canonical Wnt signaling pathway
- cell population proliferation
- cellular response to leukemia inhibitory factor
- cellular response to retinoic acid
- endothelial cell differentiation
- establishment of blood-brain barrier
- extracellular matrix-cell signaling
- locomotion involved in locomotory behavior
- negative regulation of cell-substrate adhesion
- neuron differentiation
- non-canonical Wnt signaling pathway
- Norrin signaling pathway
- positive regulation of cell migration
- positive regulation of dendrite morphogenesis
- positive regulation of DNA-templated transcription
- positive regulation of neuron projection arborization
- positive regulation of transcription by RNA polymerase II
- progesterone secretion
- regulation of vascular endothelial growth factor receptor signaling pathway
- response to hypoxia
- retina vasculature morphogenesis in camera-type eye
- retinal blood vessel morphogenesis
- sensory perception of sound
- substrate adhesion-dependent cell spreading
- vasculogenesis
- Wnt signaling pathway
- Wnt signaling pathway, calcium modulating pathway
- cerebellum vasculature morphogenesis
Molecular functions
- amyloid-beta binding
- cytokine binding
- cytokine receptor activity
- G protein-coupled receptor activity
- PDZ domain binding
- protein heterodimerization activity
- protein homodimerization activity
- protein-containing complex binding
- signaling receptor activity
- ubiquitin protein ligase binding
- Wnt receptor activity
- Wnt-protein binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of FZD4 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads FZD4 as an antibody target. Whether an autoantibody or antibody against FZD4 could matter depends on whether native FZD4 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
FZD4 is annotated at the cell surface, where native FZD4 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label FZD4 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...